CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Rating) was the target of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 169,300 shares, a decrease of 65.6% from the April 15th total of 492,500 shares. Based on an average trading volume of 91,163,800 shares, the days-to-cover ratio is currently 0.0 days.
CBDL traded down $0.00 during trading on Thursday, reaching $0.00. The stock had a trading volume of 28,747,028 shares, compared to its average volume of 83,192,695. CBD Life Sciences has a one year low of $0.00 and a one year high of $0.00.
About CBD Life Sciences (Get Rating)
CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.
See Also
Want More Great Investing Ideas?
Receive News & Ratings for CBD Life Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CBD Life Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.
Recent Comments